If you are having trouble viewing this email, view online version .

ESE Daily Alert - 11 June 2020

New drug may help treat obesity

According to a study published in EMBO Molecular Medicine, a newly discovered protein called BAM15 prevents weight gain, reduces blood sugar and may help treat obesity.


Cross-sex hormone therapy may affect metabolic profile

Gender-affirming hormone therapy may negatively affect lipid metabolism and glucose levels in transgender men, according to research published in the Journal of the Endocrine Society.

Endocrinology Advisor

Hormone replacement therapies affect brain function and structure

According to a study published in Menopause, different types of hormone therapies for women during menopause may have different affects on the structure and function of the brain.

Science Daily

New treatment for Cushing’s Syndrome now available in France

Recordati Rare Diseases have released a new treatment for Cushing’s Syndrome called Isturisa, now available in France and will be across select other European Union markets over 2020.

Business Wire

The European Society of Endocrinology is Europe’s premier learned society promoting research, education and clinical practice in endocrinology for the public benefit and representing doctors and scientists who work in endocrinology. For more information, visit http://www.ese-hormones.org/

This news alert is designed to provide European Society of Endocrinology (ESE) members with a summary of stories on endocrinology currently appearing in the media. The views expressed in the stories featured in this update are not necessarily those of the ESE. The ESE accepts no responsibility for the accuracy or completeness of the material contained in this alert.

If you know of some European media coverage that would be of interest to the ESE membership, please contact the ESE press office.

Please note that the address that sent this email is not monitored and we cannot respond to direct replies.

Stay connected